The feasibility and the effect of deprescribing in older adults on mortality and health: A systematic review

Findings

#ResourceNotFound: OAPLabels, EvidenceSummary#

Evidence Summary
Supporting technical documents that are health systems-relevant

Not usually available for this document type
Scientific Abstract

PubMed
Scientific Abstract

Publisher

Recency, quality and context of the findings

Last year literature searched

2015
Year Published

2016
Quality Rating

11/11 (AMSTAR rating from McMaster Health Forum)
Countries in which studies (included in the synthesis) were conducted

USA (36); UK (England) (14); Canada (9); Netherlands (7); Sweden (7); Australia (6); Israel (5); Belgium (4); Finland (4); Norway (4); Ireland (3); New Zealand (3); Not reported (3); UK (Scotland) (3); Spain (2); Taiwan (2); Brazil (1); Denmark (1); Europe (1); France (1); Italy (1); Japan (1); South Africa (1)
Global/regional focus

Not yet available
Country focus

USA (36); UK (England) (14); Canada (9); Netherlands (7); Sweden (7); Australia (6); Israel (5); Belgium (4); Finland (4); Norway (4); Ireland (3); New Zealand (3); Not reported (3); UK (Scotland) (3); Spain (2); Taiwan (2); Brazil (1); Denmark (1); Europe (1); France (1); Italy (1); Japan (1); South Africa (1)
Low - and middle-income country (LMIC) focus

At least one included study was conducted in a low- or middle-income country

Additional details about the research

Type of document

Systematic review of effects
Type of question

Effectiveness
Focus

Specific
Target

Health system
Priority Area

Not applicable
Health system topic(s)

Delivery arrangements
By whom care is provided
Skill mix - Multidisciplinary teams
Staff - Training
Implementation strategies
Provider-targeted strategy
Educational material
Educational meeting
Theme

Optimal aging
Domain

Technologies
Drugs
Providers
Physician
Nurse
Pharmacist

Publication details

Citation

Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and the effect of deprescribing in older adults on mortality and health: A systematic review. British Journal of Clinical Pharmacology. 2016.
DOI

10.1111/bcp.12975

Register for free access to all Professional content

Want the latest in aging research? Sign up for our email alerts.

Our Content

About

Support for the Portal is largely provided by the Labarge Optimal Aging Initiative. AGE-WELL is a contributing partner. Help us to continue to provide direct and easy access to evidence-based information on health and social conditions to help you stay healthy, active and engaged as you grow older. Donate Today.